Hopefully learned a valuable lesson. Way too early to know if that will wind up being a good purchase. Remember, even though they likely overpaid(GNBT started looking at Veneto exactly at the top of the market if you want to compare it to a stock) and had to revamp the system, they still retain access to the docs and other assets.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links